Effect of a new hypoglycemic agent, A-4166 [(-)-N-(trans-4-isopropyl- cyclohexanecarbonyl)-D-phenylalanine], on postprandial blood glucose excursion: Comparison with voglibose and glibenclamide

Biological and Pharmaceutical Bulletin

Volumn 20, Issue 4, 1997, Pages 354-359

  Ikenoue, Takao ^a   Okazaki, Kyoko ^a   Fujitani, Shoji ^a   Tsuchiya, Yoshiharu ^a   Akiyoshi, Megumi ^a   Maki, Toshio ^a   Kondo, Nobuo ^a  

^a AJINOMOTO CO INC   (Japan)

Author keywords

A 4166; glibenclamide; insulin secretion; postprandial blood glucose excursion; voglibose

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; ANTIDIABETIC AGENT; CARBOHYDRATE; GLIBENCLAMIDE; GLUCOSE; GLUCOSE OXIDASE; INSULIN; NATEGLINIDE; STREPTOZOCIN; SUCROSE; SULFONYLUREA; VOGLIBOSE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN RELEASE; MALE; NEWBORN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; POSTPRANDIAL STATE; RADIOIMMUNOASSAY; RAT; STREPTOZOCIN DIABETES;

EID: 0030971593     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.20.354     Document Type: Article

References (33)

1. Taylor S. I., Accili D., Imai Y., Diabetes, 43, 735-740 (1994).
2. Groop L. C., Widén E., Ferrannini E., Diabetologia, 36, 1326-1331 (1993).
3. DeFronzo R. A., Bonadonna R. C., Ferrannini E., Diabetes Care, 15, 318-368 (1992).
4. Kelley D., Mokan M., Veneman T., Metabolism, 43, 1549-1557 (1994).
5. Firth R. G., Bell P. M., Marsh H. M., Hansen I., Rizza R. A., J. Clin. Invest., 77, 1525-1532 (1986).
6. Groop L. C., Diabetes Care, 15, 737-754 (1992).
7. Asplund K., Wiholm B.-E., Lithner F., Diabetohgia, 24, 412-417 (1983).
8. Ferner R. E., Neil H. A. W., Br. Med. J., 296, 949-950 (1988).
9. Shinkai H., Toi K., Kumashiro I., Seto Y., Fukuma M., Dan K., Toyoshima S., J. Med. Chem., 31, 2092-2097 (1988).
10. Shinkai H., Nishikawa M., Sato Y., Toi K., Kumashiro I., Seto Y., Fukuma M., Dan K., Toyoshima S., J. Med. Chem., 32, 1436-1441 (1989).
11. Sato Y., Nishikawa M., Shinkai H., Sukegawa E., Diabetes Res. Clin. Pract., 12, 53-60 (1991).
12. Fujitani S., Yada T., Endocrinology, 134, 1395-1400 (1994).
13. Akiyoshi M., Kakei M., Nakazaki M., Tanaka H., Am. J. Physiol., 268, E185-E193 (1995).
14. Fujita T., Seto Y., Kondo N., Kato R., Biochem. Pharmacol., 52, 407-411 (1996).
15. Ikenoue T., Akiyoshi M., Fujitani S., Okazaki K., Kondo N., Maki T., Br. J. Pharmacol., 120, 137-145 (1997).
16. Lebovitz H. E., Drugs, 44, (Suppl. 3), 21-28 (1992).
17. Portha B., Levacher C., Picon L., Rosselin G., Diabetes, 23, 889-895 (1974).
18. Muto T., "Digestion and Absorption," Daiichishuppan Co., Inc., Tokyo, 1988, p. 228.
19. Polonsky K. S., Given B. D., Hirsch L. J., Tillil H., Shapiro E. T., Beebe C., Frank B. H., Galloway J. A., Cauter E. V., N. Engl. J. Med., 318, 1231-1239 (1988).
20. Porte D., Diabetes, 40, 166-180 (1991).
21. Kosaka K., Kuzuya T., Hagura R., Diabetes Res. Clin. Pract., 24, S101-S110 (1994).
22. Barnes A. J., Garbien K. J. T., Crowley M. F., Bloom A., Lancet, 1974, ii, 69-72.
23. Beck-Nielsen H., Hother-Nielsen, Pedersen O., Diabetic Med., 5, 613-620 (1988).
24. Houssay B. A., Penhos J. C., Metabolism, 5, 727-732 (1956).
25. Ratzmann K. P., Schulz B., Heinke P., Besch W., Diabetologia, 27, 8-12 (1984).
26. Joost H. G., Trends Pharmacol. Sci., 6, 239-241 (1985).
27. Sako Y., Wasada T., Umeda F., Ibayashi H., Metabolism, 35, 944-949 (1986).
28. Leclercq-Meyer V., Akkan A. G., Marchand J., Malaisse W. J., Biochem. Pharmacol., 42, 1634-1637 (1991).
29. Odaka H., Miki N., Ikeda H., Matsuo T., Jpn. Pharmacol. Ther., 19, 4439-4450 (1991).
30. Odaka H., Miki N., Ikeda H., Matsuo T., J. Jpn. Soc. Nutr. Food Sci., 45, 27-31 (1992).
31. Takami K., Odaka H., Tsukuda R., Matsuo T., Jpn. Pharmacol. Ther., 19, 4457-4465 (1991).
32. Lebovitz H. E., "Joslin's Diabetes Mellitus," ed. by Kahn C. R., Weir G. C., Lea & Febriger, Philadelphia, 1994, pp. 508-529.
33. The DCCT Research Group, N. Engl. J. Med., 329, 977-986 (1993).